(Q34451707)

English

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with pre

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with pre (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

liver cirrhosis

0 references

1 reference

ChEBI release 2020-05-28

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

7

object named as

Laurent Alric

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

12

object named as

Luis Balart

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Eric Lawitz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Edward Gane

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Brian Pearlman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Wayne Ghesquiere

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Dominique Guyader

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jean-Pierre Bronowicki

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Laura Lester

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

William Sievert

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Reem Ghalib

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Fredrik Sund

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Frank Dutko

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Melissa Shaughnessy

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Peggy Hwang

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Anita Y M Howe

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Janice Wahl

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Michael Robertson

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Eliav Barr

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Barbara Haber

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

0 references

publication date

11 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

385

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

9973

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1075-1086

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Global epidemiology and genotype distribution of the hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sofosbuvir for previously untreated chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

MK-5172, a selective inhibitor of hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis of two rates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2961795-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(14)61795-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

release_hnt7olqnwbarficdonime4pakq

1 reference

https://api.fatcat.wiki/v0/release/hnt7olqnwbarficdonime4pakq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25467591%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34451707&oldid=1971978130"